- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06754995
Diagnostic Feasibility of 100 Hz Tetanic Stimulation
Diagnostic Feasibility of 100 Hz Tetanic Stimulation in the Perioperative Setting in Patients with Normal and Abnormal ENG: a Pilot Study
Study Overview
Status
Conditions
Detailed Description
The aim of the present study is to investigate the applicability of 100 Hz tetanic stimulation with an electromyography (EMG) device. The aim is to determine whether fatigue develops with 100 Hz tetanic stimulation in anaesthetized, non-relaxed patients with normal or abnormal baseline electroneurographic (ENG) findings. Electric responses of the musculus digiti minimi elicited by supramaximal stimulation of the ulnar nerve at the carpal tunnel are monitored. Alpine Biomed ENG-EMG device with Keypoint software version 5.11 is used for the examinations. The exposed arm is fixed on the armboard, the skin is degreased and then the electrodes for monitoring are mounted lege artis. After the anesthesia has been induced, ENG of the ulnar nerve is examined. Based on the results of the ENG test, patients are divided into separate groups (normal or abnormal ENG). During the ENG test, the supramaximal current is determined. Afterwards, repetitive tetanic stimulation of the defined frequency (60 and 100 Hz) and duration (5 sec) is applied to the two test groups at the current according to the test plan.
The clinical utilities of the study results are:
- Determination of the "safety margin" of neuromuscular junction, which is not provided by routine monitoring.
- To investigate how comorbid status (especially chronic conditions affecting peripheral nerves such as polyneuropathy) influences the feasibility of tetanic stimulation in the diagnostics of residual neuromuscular block and safety margin.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Adrienn Pongrácz, MD PhD
- Phone Number: +36302390132
- Email: pongadri@gmail.com
Study Contact Backup
- Name: Réka Nemes, MD PhD
- Phone Number: +36309668722
- Email: reka.nemes.11@gmail.com
Study Locations
-
-
-
Debrecen, Hungary, 4032
- Recruiting
- University of Debrecen Medical Center, Department of Anesthesiology and Intensive Care
-
-
Hajdú-Bihar
-
Debrecen, Hajdú-Bihar, Hungary, 4032
- Not yet recruiting
- Department of Anesthesiology and Intensive Care, University of Debrecen
-
Contact:
- Adrienn Pongrácz, MD PhD
- Phone Number: +36302390132
- Email: pongadri@gmail.com
-
Contact:
- Réka Nemes, MD PhD
- Phone Number: +36309668722
- Email: reka.nemes.11@gmail.com
-
Contact:
- Mariann Fedor, MD
-
Contact:
- Adrienn Pongrácz, MD PhD
-
Contact:
- Réka Nemes, MD PhD
-
Contact:
- László Asztalos, MD PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- ASA 1-3;
- BMI 18.5-25 (normal body weight);
- patient is in supine position with one arm accessible.
Exclusion Criteria:
- diseases with impaired neuromuscular function (myopathies, severe liver and kidney failure);
- drugs affecting neuromuscular function (magnesium, aminoglycosides);
- pregnancy (pregnancy tests are carried out in women of childbearing age to rule out pregnancy);
- breast-feeding;
- acute surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Normal ENG
Patients who have normal results at baseline electroneurogrphy examination
|
|
Abnormal ENG
Patients who have abnormal results at baseline electroneurogrphy examination due to polyneuropathy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
100 Hz tetanic fade response of abductor digiti minimi muscle to ulnar nerve stimulation in patients with normal and abnormal ENG
Time Frame: From enrollment until end of anesthesia asessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
Electroneurography response of the abductor digiti minimi muscle to 100 Hz tetanic stimulation (tetanic fade) is examined to find out if there is difference in patients with or without polyneuropathy.
Tetanic fade is the decrease of the twitch heights of the compound muscle action potential due to depletion of cetylcholin stores in the nerve terminal during tetanic stimulation.
|
From enrollment until end of anesthesia asessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diagnostic feasibility of electromyography in the examination of safety margin
Time Frame: From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
To see whether tetanic stimulation with electromyography can be used as a routine tool to examine the safety margin and residual neuromuscular block.
It is expected that there will be no fade in muscle response to 60 Hz tetanic stimulation in either groups.
It is suspected that there will be no tetanic fade response to 100 Hz tetanic stimulation in patinets with normal ENG, however patinets with abnormal baseline ENG will produce tetanic fade.
The incidence and extent of tetanic fade response will be examined.
|
From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
60 Hz tetanic fade response of abductor digiti minimi muscle to ulnar nerve stimulation in patients with normal and abnormal ENG
Time Frame: From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
Electroneurography response of the abductor digiti minimi muscle to 60 Hz tetanic stimulation (tetanic fade) is examined to find out if there is difference in patients with or without polyneuropathy.
Tetanic fade is the decrease of the twitch heights of the compound muscle action potential due to depletion of cetylcholin stores in the nerve terminal during tetanic stimulation.
|
From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Béla Fülesdi, MD PhD DSci, University of Debrecen
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AITT 2024/2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polyneuropathies
-
Istituto Clinico HumanitasFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaCompleted
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Hospital Ambroise Paré ParisCompletedPostherpetic Neuralgia | Diabetic Polyneuropathies | Other PolyneuropathiesFrance, Brazil
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineNot yet recruitingPolyneuropathies
-
NovaMed Pharmaceuticals Inc.Unknown
-
Rigshospitalet, DenmarkDanish Cancer SocietyRecruiting
-
National Institute of Neurological Disorders and...Completed
-
University Medical Center GroningenCompleted
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedTechnique to Measure Type C Fibre Nerve Conduction Velocitynerve Fibers in Polyneuropathies (FIBREC)Peripheral Nervous System DiseasesFrance